Skip to content

Burden of disease of people with dementia in nursing homes measured by IPOS-Dem: a stepped-wedge cluster randomised controlled trial

Burden of disease of people with dementia in nursing homes measured by IPOS-Dem: a stepped-wedge cluster randomised controlled trial - IPOS-Dem

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00022339
Enrollment
260
Registered
2020-10-05
Start date
2020-10-12
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dementia, Alzheimer F00 F01 F02 F03

Interventions

Group 1: The study will train family members and nurses in nursing homes in their symptom assessment based on an instrument which is called IPOS-Dem (Integrated Palliative care Outcome Scale for Demen

Sponsors

Heds FR, School of Health Professions
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Nursing Homes (NH): at least 8 People with dementia (PWD), use BESA or RAI for Routine Assessment; (2) PWD: Diagnosed with Alzheimers' disease or vascular dementia OR Symptoms of Dementia documented in NH Records.; (3) Nursing Staff: At least 18 years old, employed in respective NH for at least three months with a quota equivalent to at least 20% (= working one day per week), speak german; (4) Relative: family member OR legal guardian of PWD fullfilling criteria listed above (2)

Exclusion criteria

Exclusion criteria: (1) PwD, who are hospitalised during the recruitment phase and therefore not physically in the nursing home at the time of study start; (2) Relative: family member OR legal guardian of PWD fullfilling criteria listed above (1)

Design outcomes

Primary

MeasureTime frame
The improvement (= significant improvement of p<0.05) of Quality of life in People with Dementia (PwD) measured with the QUALIDEM outcome measure. QUALIDEM is a proxy-rated, 18 item assessment instrument completed by frontline staff in nursing homes. The version used in this study assesses quality of life in people with moderate advanced dementia with regard to six dimensions and a total score. The QUALIDEM will be measured every three months for 15 months. Longitudinal, total domain scores for People with Dementia will be calculated and illustrated to demonstrate the quality of life trajectory. The primary endpoint will be assessed between baseline, and month 1-15.

Secondary

MeasureTime frame
The secondary endpoint of this study is Burden of disease (BOD): A reduction of burden of disease (BOD), measured with the total IPOS-Dem score (sum-score) in PwD compared to before and after the interventions.

Countries

Switzerland

Contacts

Public ContactAndrea Luise Koppitz

Heds FR, School of Health Professions

andrea.koppitz@hefr.ch+41 26 429 60 44

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 5, 2026